Healthy Skepticism Library item: 6515

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Mansfield P.
Re: the promotion of Prothiaden (dothiepin)
1994 Jul;

Abstract:

Boots is claiming that 96% of patients respond to treatment with Prothiaden (dothiepin) and that 94% do not experience intolerable side effects. The scientific literature does not support these claims.

Keywords:
*analysis/Australia/developed countries/Prothiaden/dothiepin/Boots/safety & risk information/efficacy/ psychotropic drugs/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: PSYCHIATRIC DISEASES